A3

Gritstone bio Presents 6-month Neutralizing Antibody (nAb) Data at ECCMID 2023 from Two Phase 1 Studies Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 (CORAL)

Retrieved on: 
星期一, 四月 17, 2023

EMERYVILLE, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today presented 6-month follow up data from its ongoing Phase 1 CORAL-CEPI and CORAL-BOOST studies, which are evaluating the company’s self-amplifying mRNA (samRNA) vaccine candidates against SARS-CoV-2, at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark.

Key Points: 
  • “Previously, we reported initial 6-month data from CORAL-BOOST showing sustained high neutralizing antibody levels in the boost setting following Vaxzevria (AstraZeneca) primary series.
  • “Current vaccines against COVID-19 have demonstrated susceptibility to loss of immunity over time, posing a greater burden on individuals and our health systems.
  • Designation as virus-naïve/convalescent was driven by baseline anti-Nucleocapsid (N) IgG serology status (negative/positive respectively).
  • To view Gritstone’s ECCMID presentations, visit ir.gritstonebio.com/investors/events .

Canon U.S.A. Introduces Industry’s First Sub-$1,000, 24-Inch Large-Format Printer with a Built-in Flatbed Scanner, Ideal for Schools, Shop Owners & More

Retrieved on: 
星期二, 四月 11, 2023

The TC-20M is compact and can fit in virtually any classroom or administrative office, and replacement Canon ink supplies are affordable for budget-strapped districts.

Key Points: 
  • The TC-20M is compact and can fit in virtually any classroom or administrative office, and replacement Canon ink supplies are affordable for budget-strapped districts.
  • Retail shop owners will benefit from the agility of the imagePROGRAF TC-20M for in-store promotion and merchandising.
  • Store signage and eye-catching promotional materials can be easily produced in minutes for window and in-store displays without the need to outsource.
  • Currently rated Gold by the Electronic Product Environmental Assessment Tool (EPEAT)2 – this is the first Canon large-format printer to earn the rating.

Wolters Kluwer receives Moody’s rating upgrade to A3

Retrieved on: 
星期四, 三月 30, 2023

Alphen aan den Rijn — March 30, 2023 — Moody's Investors Service (Moody's) has upgraded Wolters Kluwer N.V.'s senior unsecured ratings to A3 from Baa1.

Key Points: 
  • Alphen aan den Rijn — March 30, 2023 — Moody's Investors Service (Moody's) has upgraded Wolters Kluwer N.V.'s senior unsecured ratings to A3 from Baa1.
  • The outlook on the ratings remains stable.
  • Wolters Kluwer (EURONEXT: WKL) is a leading software solutions and services provider.
  • In 2022, Wolters Kluwer reported 6.2% organic revenue growth, higher than the 5.7% growth rate reported in 2021.”
    Further, “the stable outlook reflects Moody's expectation that the company's operating performance will continue to be solid, resulting in positive organic revenue growth and strong free cash flow generation.”

Automate 2023 Announces Powerhouse Lineup of Keynote Speakers

Retrieved on: 
星期四, 三月 30, 2023

ANN ARBOR, Mich., March 30, 2023 /PRNewswire/ -- Today, the Association for Advancing Automation (A3) announced the full lineup of keynote speakers for its premier North American automation showcase, Automate. Automate will feature powerful insights from five leaders across industries during keynote sessions May 22-25, 2023 in Detroit.

Key Points: 
  • Leaders from Michigan State University, NASA, Siemens, MIT and Ericsson to share insights on machine learning, 5G, digitization, team building, and more
    ANN ARBOR, Mich., March 30, 2023 /PRNewswire/ -- Today, the Association for Advancing Automation (A3) announced the full lineup of keynote speakers for its premier North American automation showcase, Automate .
  • Automate will feature powerful insights from five leaders across industries during keynote sessions May 22-25, 2023 in Detroit.
  • This year's featured speakers include leaders in sports, science, manufacturing, education and telecommunications.
  • In conjunction with the free show, the paid Automate Conference will feature accomplished industry professionals in over 150 talks.

Standard Motor Products' ABS Sensors Line Expands

Retrieved on: 
星期二, 三月 28, 2023

NEW YORK, March 28, 2023 /PRNewswire/ -- Standard Motor Products, Inc. (SMP) continues to expand its line of ABS Speed Sensors for import and domestic vehicles.

Key Points: 
  • NEW YORK, March 28, 2023 /PRNewswire/ -- Standard Motor Products, Inc. (SMP) continues to expand its line of ABS Speed Sensors for import and domestic vehicles.
  • It is widely known that the quality and performance of ABS sensors affect how long it takes a vehicle to stop, but with technology evolving, ABS sensors are being asked to do more.
  • Standard® offers more than 2,600 ABS Sensors fitting import and domestic vehicles.
  • All Standard® ABS Sensors are listed in the catalog found at StandardBrand.com , and in electronic catalog providers.

ASPINA Announces Detroit Area Office Relocation to Accommodate Accelerated Growth

Retrieved on: 
星期三, 二月 22, 2023

ASPINA America announces today that it has relocated its Detroit area office of nearly 20 years in Farmington Hills to the iconic Albert Kahn designed Burroughs Building at 4100 Plymouth Rd in Plymouth, MI.

Key Points: 
  • ASPINA America announces today that it has relocated its Detroit area office of nearly 20 years in Farmington Hills to the iconic Albert Kahn designed Burroughs Building at 4100 Plymouth Rd in Plymouth, MI.
  • The office is located on the main floor in suite 100.
  • The unique office experience caters to the surrounding Detroit culture and history while also reflecting the ASPINA brand.
  • In addition, ASPINA has joined and is supporting many local associations, including A3 (Association of Advancing Automation), Automation Alley, and Centrepolis Accelerator.

EQS-News: STRABAG SE: New record for output volume, continued high order backlog

Retrieved on: 
星期三, 二月 22, 2023

“Despite the very challenging environment in 2022, we were able to achieve a new record output volume and close the year with a very comfortable order backlog of € 23.7 billion, thereby demonstrating the resilience of our diversified business model.

Key Points: 
  • “Despite the very challenging environment in 2022, we were able to achieve a new record output volume and close the year with a very comfortable order backlog of € 23.7 billion, thereby demonstrating the resilience of our diversified business model.
  • For 2023, we do not expect any major setbacks for the STRABAG Group, although we are already noticing a shift towards more public-sector projects in our order backlog,” says Klemens Haselsteiner, CEO of STRABAG SE.
  • The STRABAG SE Group recorded a 10% increase in its output volume to € 17,735.47 million in the 2022 financial year, surpassing the previous record set in 2019.
  • On the other hand, moderate declines in output were reported in the Benelux countries as well as in Denmark, Poland and Slovenia.

NEXEN TIRE N’FERA Sport and N’Blue 4 Season tires selected as original equipment on the Audi A3

Retrieved on: 
星期二, 二月 21, 2023

SEOUL, South Korea, Feb. 21, 2023 (GLOBE NEWSWIRE) -- NEXEN TIRE, a leading global tire manufacturer, today announced that its tires have been chosen as original equipment (OE) for Audi AG's fourth-generation Audi A3 release.

Key Points: 
  • SEOUL, South Korea, Feb. 21, 2023 (GLOBE NEWSWIRE) -- NEXEN TIRE, a leading global tire manufacturer, today announced that its tires have been chosen as original equipment (OE) for Audi AG's fourth-generation Audi A3 release.
  • The N'FERA Sport and N'Blue 4 Season will be available for use on automobiles sold in Europe.
  • The N'FERA SPORT from NEXEN TIRE is a European-style premium sports tire that performs wonderfully on wet and dry road surfaces.
  • N'FERA SPORT is fitted in size 225/40R18 92Y XL and the N'Blue 4 Season in 225/45R17 94V XL.

Novel Approach to Treating Advanced Liver Cancer with Namodenoson Published in Leading Scientific Journal: 12-Month Survival of 44% for Namodenoson vs. 18% for Placebo

Retrieved on: 
星期二, 二月 14, 2023

The article includes a review of the novel approach for treating advanced liver cancer with Namodenoson, a small molecule orally bioavailable drug which specifically kills cancer cells and leaves normal liver cells unharmed.

Key Points: 
  • The article includes a review of the novel approach for treating advanced liver cancer with Namodenoson, a small molecule orally bioavailable drug which specifically kills cancer cells and leaves normal liver cells unharmed.
  • Treatment with Namodenoson resulted in longer overall survival in patients with advanced liver cancer as defined by Child Pugh B (CPB) stage in a statistically significant manner.
  • The drug has shown to have a very favorable safety profile and exert a protective effect on liver cancer cells.
  • “With Namodenoson, we are aiming to treat patients with the greatest need—those with advanced liver cancer CPB.